PFIZER INC — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-27

Reporting Person: LANKLER DOUGLAS M (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-27	Common Stock	M	53925.0000	$22.3500	Acquired	150172.0000	Direct
2021-02-27	Common Stock	F	9664.0000	$33.4900	Disposed	140508.0000	Direct
2021-02-27	Common Stock	F	34191.0000	$34.6400	Disposed	106317.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-27	Stock Appreciation Rights	$22.3500	M	53925.0000	Disposed	2021-02-27	Common Stock (53925.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1627.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: Price is the closing price of Pfizer common stock on February 26, 2021.

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.